CLOSED STUDIES / Ovarian Cancer


GEICO 0905 – OCTAVIA


Title

A single-arm Phase II clinical study of the combination of carboplatin and weekly periclitar plus bevacizumab as first-line treatment in patients with epithelial ovarian cancer.


EudraCT

2008–008336–85


GEICO Coordinator

Dr. Antonio González


Patients Recruited

48


Inclusion Closing Date

July of 2010


Current State

Following